Intra-arterial infusions stand at the forefront of innovative medical interventions, serving as a strategic conduit for delivering specialized treatments directly to designated arteries. This advanced therapeutic approach involves the meticulous administration of medicinal compounds, ranging from potent drugs to imaging agents, directly into the arterial system. The distinctive advantage of intra-arterial infusions lies in their precision, enabling the concentration of therapeutic effects to a specific anatomical site. This targeted delivery mechanism not only enhances treatment efficacy but also minimizes the impact on the broader systemic circulation, paving the way for a more refined and personalized medical strategy. The integration of intra-arterial infusions is prominently featured in the realm of interventional medicine, where skilled practitioners harness its potential to address diverse medical conditions. Cancer treatments, in particular, benefit significantly from this technique, as it allows for the direct administration of chemotherapy drugs to the tumor site. Moreover, intra-arterial infusions find application in the realm of vascular disorders, contributing to the management of conditions such as arterial blockages or aneurysms.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt